FIELD: medicine.
SUBSTANCE: invention refers to medicine, specifically to experimental cardiology and endocrinlogy, and concerns correction of hypoestrogen-induced endothelial dysfunction. For this purpose, rat females of Wistar line is daily intraperitoneally introduced with furostanol glycosides of cell culture Dioscorea deltoidea within 6 weeks after ovariectomy in dosage 1 mg/kg once a day. Method provides effective correction of endothelial dysfunction without any by-effects due to estrogen-like activity of furostanol glycosides.
EFFECT: development of effective method of correction of endothelial dysfunction without any by-effects.
1 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR HYPOESTROGEN-INDUCED ENDOTHELIAL DYSFUNCTION CORRECTION WITH MIXED SOLUTIONS OF HOMOEOPATHIC DILUTIONS OF POLYCLONAL RABBIT C12, C30, C200 ANTIBODIES TO HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE | 2010 |
|
RU2438191C1 |
METHOD FOR HYPOESTROGEN-INDUCED ENDOTHELIAL DYSFUNCTION CORRECTION WITH ENALAPRIL IN COMPLEX WITH MIXED SOLUTIONS OF HOMOEOPATHIC DILUTIONS OF POLYCLONAL RABBIT C12, C30, C200 ANTIBODIES TO HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE | 2010 |
|
RU2438189C1 |
METHOD FOR HYPOESTROGEN-INDUCED ENDOTHELIAL DYSFUNCTION CORRECTION WITH LOZARTAN IN COMPLEX WITH MIXED SOLUTIONS OF HOMOEOPATHIC DILUTIONS OF POLYCLONAL RABBIT C12, C30, C200 ANTIBODIES TO HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE | 2010 |
|
RU2437162C1 |
METHOD OF MODELLING ENDOTHELIAL DYSFUNCTION BY REPRODUCTION OF METABOLIC DISORDERS | 2009 |
|
RU2412714C1 |
METHOD OF CORRECTING ENDOTHELIAL DYSFUNCTION BY MEDICATION "ETOXYDOL" IN CASE OF L-NAME INDUCED NITROGEN OXIDE DEFICIENCY | 2010 |
|
RU2433486C1 |
METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY COMBINATION OF ENALAPRIL AND RESVERATROL IN L-NAME-INDUCED DEFICIENCY OF NITROGEN OXIDE | 2005 |
|
RU2301670C1 |
METHOD FOR CORRECTING ENDOTHELIAL DYSFUNCTION WITH COMBINATION OF INDAPAMIDE AND RESVERATROL AT L-NAME-INDUCED DEFICIENCY OF NITROGEN OXIDE | 2005 |
|
RU2302241C1 |
METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION BY COMBINATION OF TRIMETAZIDINE AND L-ARGININE IN L-NAME-INDUCED NITROGEN OXIDE DEFICIENCY | 2009 |
|
RU2421822C2 |
METHOD FOR RECOMBINANT ERYTHROPOIETIN CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITROGEN OXIDE DEFICIENCY | 2009 |
|
RU2409873C1 |
METHOD OF CORRECTING ENDOTHELIAL DYSFUNCTION WITH COMBINATION OF LOZARTAN AND RAZVERATROL IN CASES OF LONAME-INDUCED NITROGEN MONOXIDE DEFICIENCY | 2005 |
|
RU2306924C1 |
Authors
Dates
2008-07-27—Published
2006-07-14—Filed